Lanean...
AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer
Gene therapy with adeno-associated virus (AAV) vectors has demonstrated safety and long-term efficacy in a number of trials across target organs, including eye, liver, skeletal muscle, and the central nervous system. Since the initial evidence that AAV vectors can elicit capsid T cell responses in h...
Gorde:
| Argitaratua izan da: | Mol Ther |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
American Society of Gene & Cell Therapy
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7054726/ https://ncbi.nlm.nih.gov/pubmed/31972133 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2019.12.010 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|